We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.
Add this topic to your myFT Digest for news straight to your inbox
What could possibly go wrong?
Plus, activist investors circle Salesforce and Bill Ackman gets in on the watch game
Et tu, Lone Pine?
Ken Griffin’s hedge fund charged investors $12bn in fees and expenses in 2022
The third quarter of last year had 71 new funds, down from 132 in the same period of 2021
We just live in it
Northwest Biotherapeutics claims Citadel Securities, Virtu and others drove down its share price
One style to rule them all, and in the alpha bind them
Billionaire investor joins chorus of voices anticipating pain for American economy
Citadel and Point72 among firms betting against companies including Abrdn and Ashmore
Computer engineers are returning to finance after a reversal of fortune in the war for talent
Lenders line up to provide financing after volatility spurs profit gains for US equities trading house
Departures of Boeing, Caterpillar and Citadel headquarters come as leaders fret over crime
SEC proposal requiring dealer registration would increase capital requirements and scrutiny
Hedge fund is latest US company to depart Illinois in less than two months
Plus, Robinhood plans to step into the UK crypto scene and US law firms get into a new kind of promotion
Caxton’s $11bn macro fund is raising its fees and breaching industry standards
Upbeat start to 2022 comes during a strong run for multi-strategy hedge funds
Involved in more than 25 per cent of all US stock trades, and tipped to float, the company is the focus of SEC scrutiny
Plus, Ken Griffin’s crypto play, Terry Smith on mayonnaise, and UK fund outflows
Citadel Securities deal is latest in string of successes for controversial hedge funder
And Ken Griffin hedges his bets
Plus, Google steps up its Brussels lobbying and companies embark on a borrowing binge
Deal values trading firm at $22bn and paves way for initial public offering
Some Wall Street firms relax efforts to get staff back into offices as infections rise
International Edition
